1. Home
  2. GRDX vs GLMD Comparison

GRDX vs GLMD Comparison

Compare GRDX & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GRDX

GridAI Technologies Corp. Common Stock

N/A

Current Price

$2.45

Market Cap

8.1M

Sector

Health Care

ML Signal

N/A

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

HOLD

Current Price

$1.17

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDX
GLMD
Founded
N/A
2000
Country
United Kingdom
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
6.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
GRDX
GLMD
Price
$2.45
$1.17
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
121.2K
6.3M
Earning Date
11-19-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$0.74
52 Week High
$4.49
$3.61

Technical Indicators

Market Signals
Indicator
GRDX
GLMD
Relative Strength Index (RSI) N/A 58.23
Support Level N/A $0.81
Resistance Level N/A $0.99
Average True Range (ATR) 0.00 0.10
MACD 0.00 0.04
Stochastic Oscillator 0.00 97.90

Price Performance

Historical Comparison
GRDX
GLMD

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Share on Social Networks: